← Eichor
Condition: Fuchs Endothelial Corneal Dystrophy Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Fuchs Endothelial Corneal Dystrophy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

SUCCESS Score Validation in Fuchs Dystrophy
Phase N/A · 1 location(s) · Instituto Ramón y Cajal de Investigación Sanitaria · NCT07265388Safety and Efficacy of Tissue Engineered Endothelial Keratoplasty
Phase 1 · 1 location(s) · Singapore Eye Research Institute · NCT04319848Glanatec(R) for Descemet Stripping in Fuch's Endothelial Dystrophy
Phase 4 · 1 location(s) · Marian Macsai, MD · NCT03249337Effect of Descemet Membrane Polishing in Fuchs Endothelial Corneal Dystrophy
NA · 5 location(s) · Centre Hospitalier Universitaire de Saint Etienne · NCT07539012The OPTIMISE Study
Phase 4 · 8 location(s) · Maastricht University Medical Center · NCT05716945Comparison of Outcomes Between Femtosecond Laser-Assisted and Conventional Phacoemulsification in Fuchs Endothelial Corn
Phase N/A · 1 location(s) · Eye & ENT Hospital of Fudan University · NCT06966167Study to Assess Safety and Tolerability of Multiple Doses of EO2002
Phase 1 · 1 location(s) · Asociación para Evitar la Ceguera en México · NCT05636579A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia
Phase N/A · 1 location(s) · Massachusetts General Hospital · NCT02118922DT-168 in Keratoplasty Patients With Fuchs Endothelial Corneal Dystrophy
Phase 2 · 2 location(s) · Design Therapeutics, Inc. · NCT07024693Plasma Rich in Growth Factors in Corneal Endothelial Transplantation
NA · 2 location(s) · University of Miami · NCT06261346Prognosis of Posterior Lamellar Keratoplasty
Phase N/A · 1 location(s) · Centre Hospitalier Régional Metz-Thionville · NCT06859411Analysis of the Genotype/Phenotype Relationship in the Fuchs' Corneal Endothelial Dystrophy in France
Phase N/A · 1 location(s) · Centre Hospitalier Universitaire de Saint Etienne · NCT05742321OCT in Fuchs' Dystrophy
Phase N/A · 1 location(s) · Oregon Health and Science University · NCT04258787Targeting Reactive Oxygen Species Production as a Novel Therapeutic in Fuch's Endothelial Corneal Dystrophy
Phase 2 · 1 location(s) · Massachusetts Eye and Ear Infirmary · NCT04440280The Effects of Ripasudil in Patients With FED Undergoing Femtosecond Laser Assisted Cataract Surgery
Phase 3 · 1 location(s) · Singapore Eye Research Institute · NCT06048380Descemet Endothelial Thickness Comparison Trial II
Phase 3 · 8 location(s) · Stanford University · NCT05275972FECD-TRACE: Fuchs' Endothelial Corneal Dystrophy TRAjectory and Correlation With Genotype in the United Kingdom
Phase N/A · 1 location(s) · University College, London · NCT06881771The Belgian Endothelial Surgical Transplant of the Cornea
NA · 11 location(s) · University Hospital, Antwerp · NCT05436665PVEK Corneal Implant For Treatment of Corneal Edema
Phase 1 · 3 location(s) · Precise Bio · NCT07325097Endothelial Side Up Inverted Femtosecond Laser Assisted DSAEK
NA · 1 location(s) · Dar El Oyoun Hospital · NCT06652321Trial Comparing Cataract Surgery With Triple-DMEK in Patients With Cataract and Fuchs Endothelial Corneal Dystrophy
NA · 4 location(s) · University of Cologne · NCT06425666Influence of Supine Positioning on the Outcomes After Descemet Membrane Endothelial Keratoplasty (DMEK)
NA · 1 location(s) · University Hospital Heidelberg · NCT07373821DISCOVER Study: Microscope-integrated Intraoperative OCT Study
Phase N/A · 1 location(s) · The Cleveland Clinic · NCT02423213
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.